NCT00498043View on ClinicalTrials.gov

A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Lymphoma, B-CellLymphoma, Large-Cell, Diffuse
Interventions
DRUG

R-CHOP14 induction regimen

R-CHOP14 induction regimen

DRUG

R-ACVBP14 induction regimen

R-ACVBP14 induction regimen

Trial Locations (1)

21000

René Olivier Casasnovas, Dijon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT00498043 - A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma | Biotech Hunter | Biotech Hunter